A NOTE FROM THE OUTGOIN PRESIDENT, Kate Fitzgerald:

A NOTE FROM THE OUTGOING PRESIDENT, Kate Fitzgerald:

by CytokineSociety in President's Letter

It has been an honor and privilege to serve as President of the ICIS. I want to express my gratitude to you all for your membership and the continued success of our conferences.  It has certainly been a unique time to lead the Society over the last two years. It seems in many ways, a seismic shift has occurred in all aspects of our lives, changing the way we live, work, and commune with each [READ MORE]

2021 Election Results

  • Please click on the images for Mini-Bios: Officers – 2 year terms Sarah L. Gaffen, PhD, President-Elect (2021 – 2023) Dusan Bogunovic, PhD, Treasurer (2021-2023) Council Members – 3 year terms Judith E Allen, FRSE, FRSB, FMedSci, Council (2022-2024) You-Me Kim, PhD, Council (2022 – 2024) Nominations Committee – 3 year terms Rune Hartmann, PhD, Nominating Committee (2022 – 2024) Lydia Lynch, PhD, Nominating Committee (2022 – 2024) Council member or for Inclusion and Training, [READ MORE]

Cytokines 2021 Virtual Meeting

Cytokines 2021 Virtual Meeting

As communicated previously, the ever-changing uncertainties associated with the current pandemic has placed various pressures on the organization of our forthcoming Cytokines2021 meeting. After careful reflection, the ICIS has made the hard decision to transfer the annual meeting to a FULLY VIRTUAL conference. This decision will safeguard the health and wellbeing of our delegates and alleviate the stress related to the uncertainties of traveling and in-person gatherings. [READ MORE]

Related Meeting Reviews

  • Guest ICIS Symposium at virtual AAI meeting IMMUNOLOGY2021, May 13, 2021 Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity The symposium started with a brief overview of type III IFNs by Sergei Kotenko, Rutgers University. He covered discoveries leading to the identification of this cytokine family and their receptor complex, introduced individual members of the IFN-lambda family, described the basic biology of type III IFNs, and reviewed their known functions. [READ MORE]
  • The Annual International Meeting of Korean Association of Immunologists (KAI 2021) was held on June 2 – 4, 2021 at the Swiss Grand Hotel in Seoul, Korea. Despite the continuing global COVID-19 pandemic and a strict social distancing policy in Korea, the on/offline hybrid meeting was highly successful with about 900 participants (181 abstracts) from 21 countries. The scientific program included 4 plenary lectures, 14 Major Symposia, 3 Satellite Symposia, 6 Workshops, 2 Education Sessions, [READ MORE]

News

The ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020)

The ICIS-Pfizer Award for Excellence in Interferon and Cytokine Research (formerly the Seymour & Vivian Milstein Award from 1988 – 2020), represents the pinnacle of scientific achievement in interferon and cytokine research since 1988, two years after interferon was first approved for the treatment of hairy cell leukemia. Since that time, it has been widely recognized that interferons and the larger class of cytokines play critical roles in the development and progression of many major diseases including cancer, viral diseases such as hepatitis and influenza, and autoimmune disorders like multiple sclerosis and lupus. [READ MORE]

Pfizer Trainee Awards for Most Promising Research Presentations at the Cytokines Annual Meeting

All ICIS member trainees (students, postdocs and fellows) are invited to apply for a Pfizer Trainee Award at the time of abstract submission, before the June 1, 2021 deadline.

Up to four (4) trainees with the highest scoring abstracts as per the scientific review committee, will be awarded $1,250 each and will be invited to give an oral presentation at Cytokines 2021 Hybrid Meeting, recognized as a PfizerTrainee Presentation, in the most appropriate session based on topic. [READ MORE]

2021 Vilcek Foundation Prizewinners in Biomedical Science

The Vilcek Foundation Prizes in Biomedical Science celebrate the contributions of immigrant scientists to biomedical research and discovery in the United States
The Vilcek Foundation has announced the recipients of the 2021 Vilcek Foundation Prizes in Biomedical Science. Ruth Lehmann, director of the Whitehead Institute for Biomedical Research is the recipient of the 2021 Vilcek Prize in Biomedical Science. The 2021 Vilcek Prizes for Creative Promise in Biomedical Science are presented to Mohamed Abou Donia, Ibrahim Cissé, and Silvi Rouskin. [READ MORE]

New Member Mini-Bios

Douglas Philip Dyer, Ph.D.

Douglas Philip Dyer, Ph.D. Sir Henry Dale Fellow Wellcome Centre for Cell-Matrix Research, University of Manchester, UK Twitter: @tripledougdyer  Dr. Dyer undertook his Ph.D. research investigating how an anti-inflammatory protein functions by disrupting the interactions between chemokines and [READ MORE]

Hector Huerga Encabo, Ph.D.

Hector Huerga Encabo, Ph.D. Post-doctoral Fellow Haematopoietic Stem Cell Laboratory The Francis Crick Institute London, United Kingdom Twitter: @DrHHEncabo and @TReNDinAfrica Postdoctoral Fellow at The Francis Crick Institute (London, UK), he received the Kay Kendall Leukemia fellowship to develop his research [READ MORE]

Olha Yaroshko

Olha Yaroshko Ph.D. Candidate and Graduate Research Assistant Institute of Cell Biology and Genetic Engineering NAS of Ukraine Kyiv, Ukraine Olga Yaroshko is a Ph.D. student in Biotechnology at the Institute of Cell biology and Genetic Engineering, NAS, [READ MORE]

Jakob von Moltke, Ph.D.

Jakob von Moltke, Ph.D. Assistant Professor University of Washington Department of Immunology Seattle, USA Twitter: @jakob_moltkeDr. von Moltke is an Assistant Professor in the Immunology Department at the University of Washington Medical School in Seattle. Dr. von Moltke graduated with [READ MORE]

Amanda Rae Mannino, MLS (ASCP)

Amanda Rae Mannino, MLS (ASCP)CM Ph.D. Candidate and Graduate Research Assistant UT Health San Antonio San Antonio, USA Amanda Mannino’s research focuses on simian immunodeficiency virus, the nonhuman primate (NHP) analog of HIV, and its restriction in baboons. The [READ MORE]

GuanQun ‘Leo’ Liu, Ph.D.

GuanQun ‘Leo’ Liu, Ph.D. Postdoc Fellow Cleveland Clinic Florida Research and Innovation Center Port St. Lucie, USA Twitter: @leonardliu88 Dr. GuanQun ‘Leo’ Liu is a postdoctoral fellow in the laboratory of Prof. Michaela Gack at the Cleveland Clinic Florida Research [READ MORE]

Michail Lionakis, MD, Sc.D.

Michail Lionakis, MD, Sc.D. Chief, Fungal Pathogenesis Section Deputy Chief, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health Twitter: @LionakisLab https://www.niaid.nih.gov/research/michail-s-lionakis-md-scd Dr. Lionakis is a physician-scientist and Head of the Fungal [READ MORE]

Ai Ing Lim, Ph.D.

Ai Ing Lim, Ph.D. Postdoctoral Research Fellow Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, USA Twitter: @AiingLim I view science as an adventure into the unknown. How [READ MORE]

Clinical Trials

Clinical Trials

By Marta Catalfamo Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients Principal Investigators: Brahm H Sega, MD. Roswell Park Cancer Institute. Buffalo, New York, United States, 14263 Contact: Brahm H. Segal, MD, Phone: [READ MORE]

Special Article of Interest

  • Since the first report of SARS-CoV-2 from Wuhan, back in December 2019, the pandemic has ravaged the world with ever-evolving different variants-with changing dominance patterns. Different variant of concerns (alpha, beta, gamma, delta and kappa) with corresponding spike mutations, rendering evasion of the immune system and making them varyingly resistant to different vaccines (1). Presently, [READ MORE]

Industry News

  • By Supreet Agarwal Cytokines represent the major class of all the soluble ligands targeted by FDA-approved drugs  Major cytokines’ (interferons, interleukins and chemokines) targeted therapies Figures adapted from:Attwood, M.M., Jonsson, J., Rask-Andersen, M. et al. Soluble ligands as drug targets. Nat Rev Drug Discov 19, 695–710 (2020). https://doi.org/10.1038/s41573-020-0078-4 Cytokines based therapies approved in 2020Two new treatments for patients with a condition called, deficiency of interleukin-1 receptor antagonist, a very rare genetic inflammatory condition resembling an infection throughout the body or a bone [READ MORE]

Other Meetings of Interest

Signals+ PDF

  • Signals+ Newsletter in PDF format for viewing, downloading and/or printing. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)

Stay connected & please share